BCL2 and craniosynostosis: Studies have shown that CSO can inhibit the activity of HT-29 cells in a time/dose-dependent manner in vitro assays; CSO can induce apoptosis by modulating the PI3K/AKT signaling pathway, activating caspase-3, upregulating Bax and downregulating Bcl-2 (95).